Masato Ooka

National Institutes of Health

Papers

1

Total Citations

49

H-Index

1

About

Masato Ooka is a leading figure in the advancement of in vitro toxicology, with a primary focus on high-throughput screening (HTS) methodologies to revolutionize chemical safety assessment. His seminal work, "High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions" (2023, 49 citations), critically examines the limitations of traditional animal-based toxicity testing—which is costly, low-throughput, and often poorly predictive of human responses—and champions the adoption of HTS to address the growing backlog of untested chemicals and high drug-candidate failure rates. Ooka’s contributions lie in systematically evaluating the successes and hurdles of integrating HTS into regulatory toxicology, highlighting how these technologies can accelerate hazard identification and reduce reliance on animal models. His research has been instrumental in shaping discussions around the transition to more human-relevant, efficient testing paradigms. With a growing citation impact, Ooka’s work serves as a vital resource for toxicologists, pharmacologists, and policymakers seeking to modernize safety evaluation, ultimately aiming to improve public health outcomes through more predictive and ethical science.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions
49 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago